Health and Fitness
Health and Fitness
Tue, June 1, 2010
[ 04:00 PM ] - Market Wire
[ 04:00 PM ] - Market Wire
[ 04:00 PM ] - Market Wire
[ 04:00 PM ] - Market Wire
[ 04:00 PM ] - Market Wire
[ 02:58 PM ] - Market Wire
[ 11:46 AM ] - Market Wire
[ 07:12 AM ] - Market Wire
[ 07:02 AM ] - Market Wire
[ 06:30 AM ] - Market Wire
[ 06:18 AM ] - Market Wire
[ 06:03 AM ] - Market Wire
[ 06:00 AM ] - Market Wire
[ 05:30 AM ] - Market Wire
[ 04:30 AM ] - Market Wire
Protox to present Phase 2b BPH data at the Annual Meeting of the American Urological Association
Session: Late-Breaking Science Forum Title: Results of a Phase IIb Double-Blinded Placebo-Controlled Study of Transperineal Intraprostatic Injection of a PSA-Activated Protoxin (PRX 302) in Patients with Moderate to Severe LUTS Location, Date and Time: Moscone South, Room 103, Tuesday, June 1, 2010, 1:00 PM (PST) Session: Benign Prostatic Hyperplasia; Medical and Hormonal Therapy Title: Evaluation of Transperineal Prostatic Administration of a PSA activated Protoxin (PRX302) in Men with LUTS secondary to BPH Location, Date and Time: Moscone North Building, Room 120, Podium 52, Tuesday, June 1, 2010, 3:30 PM (PST)
Contributing Sources